感谢您提供的信息。现在您可以查看该资源了。

Abbott Informatics ELN solution helped ImClone reduce cycle times and capture method data

下载 (PDF327.0 KB)

2013年11月7日

Abbott Informatics ELN solution helped ImClone reduce cycle times and capture method data

Company Background

In 2010, ImClone, a wholly-owned subsidiary of Eli Lilly implemented a fully automated LIMS process from STARLIMS Corporation to replace the paper based process used in their quality testing labs. The automated LIMS system enabled ImClone to accommodate a 25% increase in testing volume while holding headcount steady. The manufacturing of pharmaceutical drugs is a complex process requiring multiple validation checks to ensure patients get a safe and efficacious product. ImClone has implemented rigorous testing processes to ensure manufactured lots meet stringent quality control standards. The quality control process takes samples off manufacturing lines and tests them against defined test processes to ensure all quality standards are met.

 

Challenge

Scientists in the laboratory were capturing results and ancillary data associated with the test method in log books or other forms. The results were then transcribed manually into the STARLIMS LIMS application. The manual component introduces delays and the potential for errors due to human transcription. In addition, the process required manually tracking a lot of data.

 

Solution

The ImClone team considered several solutions for Electronic Lab Notebooks (ELN). The team selected STARLIMS ELN primarily due to the tight, seamless integration with STARLIMS and STARLIMS SDMS

 

Benefits
Reduced cycle times and errors for review & testing

By eliminating the use of paper to capture ancillary method data, ImClone was able to reduce cycle times for testing and review. This was especially true for assays which extended over several days. In addition, errors due to transcription could be eliminated as the data would be automatically fed into the STARLIMS LIMS system. The tight integration with STARLIMS SDMS ensured instrument and other kinds of data were automatically parsed and available for use without the need for transcription. Scientists could get the instrument report, upload it to STARLIMS ELN where it is parsed and added to the sample submission, and then the calculation would be completed automatically. Finally, scientists were able to reduce the risk of having to repeat tests because they could make sure all the data was matched correctly to the sample submission within an electronic system. 

 

Powerful flexibility through an Excel-like interface

ImClone scientists were impressed by the interface to STARLIMS ELN which looked just like Excel. Many of ImClone’s current paper based forms were built in Microsoft Word or Excel. These forms could be easily mirrored in STARLIMS ELN, easing the transition to the electronic notebook process. STARLIMS ELN provided a familiar layout for them. In addition, the flexible ELN canvas in STARLIMS ELN allowed scientists to capture unstructured data, such as charts and graphs, and to annotate pictures. The flexibility of STARLIMS ELN enabled ImClone to configure the ELN based on their processes rather than forcing ImClone to follow a pre-defined process.

 

Results

STARLIMS ELN was very well received by the lab scientists. Implementing ELN on the SDS assay has reduced turnaround time by two hours on average (50%). Implementing ELN on the endotoxin assay has reduced turnaround time by one hour on average (29%). And even labs which were previously reluctant to embrace the electronic format now wanted to use ELN for other assays.

填写下表以查看更多信息。

"We were impressed by the flexibility of the StarLIMS ELN, which allowed us to configure the system to fit our processes, rather than being forced into a set path. In addition, our people loved the fact that the StarLIMS ELN looks like an Excel spreadsheet, and we could set it up to mirror the way the paper forms looked."

Eric Natchman
Supervisor, ImClone Systems

您即将退出面向第三方网站的 ABBOTT 系列网站

使您离开 Abbott 全球网站的链接不受 Abbott 控制;对于任何此类网站的内容或者来自此类网站的任何进一步链接,Abbott 概不负责。Abbott 向您提供这些链接仅为方便之用,包含任何链接并不意味着所链接的网站已获 Abbott 认可。您已请求的网站的屏幕尺寸对您而言也可能并非最佳尺寸。

您希望继续并进入该网站吗?

是的 没有

您将进入 Abbott 为某个特定国家或地区建立的网站。

请注意,您请求的网站适用于某一特定国家/地区或多个国家/地区的居民,具体如该网站所述。因此,该网站包含的信息可能涉及尚未在其他国家或地区获得批准的药品、医疗设备和其他产品或其用途。

您希望继续并进入该网站吗?

是的 没有

您将进入 Abbott 为某个特定国家或地区建立的网站。

请注意,您请求的网站适用于某一特定国家/地区或多个国家/地区的居民,具体如该网站所述。因此,该网站包含的信息可能涉及尚未在其他国家或地区获得批准的药品、医疗设备和其他产品或其用途。

您希望继续并进入该网站吗?

是的 没有

联系我们